Table 4.
Effect of FXC on the hematology (×103/μl) in carrageenan induced exudate in the air pouch
| Dose/route | Neutrophils | Monocytes | Lymphocytes | WBCs | |
|---|---|---|---|---|---|
| Saline | 2 ml i.p. | 0.150 ± 0.009d | 0.079 ± 0.010d | 0.472 ± 0.040d | 0.945 ± 0.0982d |
| Carrageenan | 10 ml/kg p.o. | 6.027 ± 0.350a | 1.972 ± 0.136a | 12.665 ± 1.456a | 23.422 ± 1.556a |
| Diclofenac sodium | 10 mg/kg p.o. | 4.494 ± 0.172c | 1.445 ± 0.114bc | 10.978 ± 1.231ab | 17.521 ± 1.201b |
| FXC | 100 mg/kg p.o. | 5.082 ± 0.238b | 1.665 ± 0.125b | 9.240 ± 0.857b | 16.932 ± 0.974b |
| FXC | 200 mg/kg p.o. | 4.285 ± 0.153c | 1.353 ± 0.122c | 5.698 ± 0.483c | 12.199 ± 1.571c |
FXC = F. xanthoxyloides chloroform fraction. Count of cells is presented as mean ± SD (n = 6). One way analysis of variance for count of cells was followed by multiple comparisons by Tukeys’ HSD test. Superscript alphabets indicate significance among treatments (P <0.001) on not sharing common letter